HKSE - Delayed Quote HKD

WuXi AppTec Co., Ltd. (2359.HK)

Compare
54.150
+2.150
+(4.13%)
At close: January 14 at 4:08:04 PM GMT+8
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for 2359.HK

Recent News: 2359.HK

View More
WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)

WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)
PR Newswire 2 days ago
WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year

WuXi AppTec's Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year
PR Newswire 15 days ago
WuXi AppTec Receives Gold Medal in 2024 EcoVadis Sustainability Rating

WuXi AppTec Receives Gold Medal in 2024 EcoVadis Sustainability Rating
PR Newswire last month
WuXi AppTec's Couvet Site Receives EcoVadis 2024 Silver Medal Rating

WuXi AppTec's Couvet Site Receives EcoVadis 2024 Silver Medal Rating
PR Newswire last month
WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment

WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment
PR Newswire 2 months ago
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year

WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
PR Newswire 2 months ago
Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY

Despite External Challenges, WuXi AppTec Revenue and Profit Continued to Grow QoQ in the First Three Quarters of 2024; the Third Quarter Revenue Back to RMB 10+ Billion, Up 14.6% YoY Excluding COVID-19 Commercial Projects; Backlog Up 35.2% YoY
PR Newswire 2 months ago
US bill to restrict business with China's WuXi AppTec, BGI passes House

US bill to restrict business with China's WuXi AppTec, BGI passes House
Reuters 4 months ago
Despite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected, with Revenue Up 16.0% QoQ and Adjusted Non-IFRS Net Profit Up 28.5% QoQ

Despite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected, with Revenue Up 16.0% QoQ and Adjusted Non-IFRS Net Profit Up 28.5% QoQ
PR Newswire 5 months ago
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations

WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations
PR Newswire 8 months ago
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time

WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time
PR Newswire 9 months ago
View More

Related Tickers

2268.HK WuXi XDC Cayman Inc.
29.450
+1.90%
 
XWEL XWELL, Inc.
1.3696
+0.71%
 
MTD Mettler-Toledo International Inc.
1,271.36
+0.33%
 
ERF.PA Eurofins Scientific SE
46.08
-5.98%
 
LONN.SW Lonza Group AG
537.40
-1.29%
 
IDXX IDEXX Laboratories, Inc.
418.63
-0.94%
 
VCYT Veracyte, Inc.
41.06
-4.02%
 
WAT Waters Corporation
404.93
+1.27%
 
MEDP Medpace Holdings, Inc.
330.91
-5.99%
 
APDN Applied DNA Sciences, Inc.
0.1825
-5.64%